Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: ACR Highlights
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: RA On The Rise In Women
D Scott Cunningham MD, PhD, MDLinx Rheumatology
  See all
tissue factor-initiated inflammation Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Essential role of platelet activation via PAR-4 in tissue factor-initiated inflammation
Arthritis Research & Therapy, 04/21/08
Print     Email This Article     Save in My Library   Free Abstract
Busso N et al. - Soluble tissue factor (sTF) induces acute inflammation through a thrombin-dependent pathway and both fibrin deposition and platelet activation are essential steps in this process. The activation of protease activated receptor-4 (PAR-4) on platelets is crucial and the other PARs do not play a major role in sTF-induced inflammation.

Methods
  • Mechanisms behind the TF activation of the coagulation proteases enhancing inflammation in arthritis and endotoxemia were studied
  • Extravascular inflammation was induced by injection of recombinant sTF1-219 in the hind paw
  • Effects of thrombin inhibition, fibrinogen and platelet depletion were evaluated
  • Effects of PAR deficiency using knockout mice deficient for each of the PARs was also investigated

Results
  • Injection of sTF provoked a rapid onset of paw swelling
  • Inflammation was confirmed histologically and by increased serum IL-6 levels
  • Inflammation was reduced by depletion of fibrinogen or platelets, by treatment with hirudin or an inhibitor of Factor VIIa
  • PAR-4 deficient mice exhibited a reduced paw swelling
  • In contrast, a deficiency in either PAR-1, PAR-2- or PAR-3 did not affect the inflammatory response to sTF injection

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.